ML18220B372
| ML18220B372 | |
| Person / Time | |
|---|---|
| Site: | 03014529 |
| Issue date: | 07/26/2018 |
| From: | Simmons M R NRC Region 4 |
| To: | Straub Clinic & Hosp |
| References | |
| 608699 | |
| Download: ML18220B372 (3) | |
Text
NRC FORM 374 U.S. NUCLEAR REGULATORY COMM I SS I ON MATERIALS LICENSE PAGE 1 OF 3 PAGES Amendment No. 31 Corrected Copy Pursuant to t he Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Pub li c Law 93-438), and Title 10 , Code of Federa l Regu l at i ons, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in relia nce on statements and rep resen tations heretofore made by t he li censee, a li cense i s he reby i ssued authoriz in g the licensee to rece i ve, acqu i re, possess, and tra ns fer byproduct , source, and spec i a l n uclear materia l designated be l ow; to use such mater i al for t he purpose(s) and at the p l ace(s) des i gnated below; to deliver or t r ansfer such mate rial. to persons authorized to rece ive it in accordance with the reg ulations of the app li cab l e Part(s). This li cense shall be deemed to conta i n the conditions spec ifi ed in Section 183 of the Atom i c Energy Act of 1954, as amended, and i s sub j ect to a ll app li cab l e ru l es, regu l ations, and orde r s of t he Nuc l ear Regu l atory Commission now or he reafter in effect and t o any conditions specified below. Licensee 1. Straub Clinic & Hospital Departme nt of Nuclear Medicine 2. 888 South King Street Honol ulu, HI 96813 6. Byproduct, so ur ce, and/or spec i a l nuclear mate r i al A. Any byproduct material permitted by 10 CFR 35.100 B. Any byproduct material permitted by 10 CFR 35.200 C. Any byproduct mater i a l permitted by 10 CFR 35.300 D. Any byproduct material permitted by 10 CFR 31.11 7. Chemica l A. Any B. Any C. Any D. Prepackaged Kits 4. Expiration Date: October 31, 2025 r---------
L....,..::=i
....--~ 5. Docket No.: 030-14529 D. 5 mi lli cur i es total Reference No.: 9. Authorized use A. For use in uptake, dilut i on and excretion stud i es perm itt ed by 10 CFR 35.100. B. For use in imaging and local i zation stud i es permitted by 10 CFR 35.200. C. For any use perm itt ed by 1 O CFR 35.300. D. For use in in-vitro stud i es. E. Yttrium-90 E. Liquid (IDEC Pharmaceuticals E. Not to exceed 2 sources, 110 m illi curies total activity E. To be used for dose calibration checks and cal i brations and qua l ity assurance testing. Zevalin,)
NRC FORM 374A MATERIALS LICENSE SUPPLEMENTARY SHEET U.S. NUCLEAR REGULATORY COMMISSION License Number 53-18126-01 Amendment No. 31 (Corrected Copy) CONDITIONS Docket or Reference Number 030-14529 PAGE 2 OF 3 PAGES 1 O. Licensed material may be used or stored only at th;.:{"pt'f\
fa~t~~;88 South King Street, Honolulu, Hawaii (island of Oahu). Id W. Frick, M.S., CHP, D AB R. r 0 11. The Radiation Safety Officer for this license i~ 12. Licensed material shall only be used b y , ~nd er the..._supervision of: A. Individuals permitted to work as au with 10 CFR 35.13 and 10 CFR 35 B. The following individuals are autho Authorized User(M.D.,D.O.,etc.)
Marc Goel, M.D. Brandon ltagaki, M.D. Shay J. Lee, M.D. Douglas A. Prager, M.D. Brian T. Sinclair, M.D. Kristi Takaki , M.D. ~o authorized medical physicists, in accordance
- 13. Sealed sources containing licensed material shall not be opened or sources removed from source holde rs by the licensee, except as specifically authorized.
- 14. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the limits spec i fied in 10 CFR 30. 72 which require consideration of the need for an emergency plan for responding to a release of licensed material.
NRC F ORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 3 OF 3 PAGES MAT E RIALS LICENSE SUPPL E M E NTARY SHEET License Number 53-18126-01 Amendment No. 31 (Corrected Copy) Docket or Reference Number 030-14529
- 15. Except as specifically provided otherwise in this license, the licen~e s h a ll conduct its program in accordance with the statements, rep r esentations, and procedures contained in th e do c~ebt~nc[Cfc li i 0 Y.1 0Jl c losures, listed below. This license condition applies only to those p rocedures that are required to be submitted~ac c~an ce with th e ~~~9 n s. Additionally, this license condition does not limit the licensee's ability to make changes to the radiaa~f..p r otection p rogram a s provide a-f w" i n 10 CFR 35.26. The U.S. Nuclear Regulatory Commis sion's regulations shall govern unl~h e statements, represen tations, and p~e dures in the licensee's application and correspondence are more restrictive than t eg ulations.
A. Letter with enclos ures dated Novem B. Application dated April 6, 2015 (M L 1 I C. L etter dated October 8, 2015 (ML1 5 Dat e: July 23, 2018 Cl.) (/) '</1-'. /) C'l 0 s ~o FOR THE U.S. NUCLEAR E EGULATORY COMMISSION By: c&~< Michelle R. Simmons Region 4